DE69922090D1 - Austausch von T-Lymphozyten - Google Patents

Austausch von T-Lymphozyten

Info

Publication number
DE69922090D1
DE69922090D1 DE69922090T DE69922090T DE69922090D1 DE 69922090 D1 DE69922090 D1 DE 69922090D1 DE 69922090 T DE69922090 T DE 69922090T DE 69922090 T DE69922090 T DE 69922090T DE 69922090 D1 DE69922090 D1 DE 69922090D1
Authority
DE
Germany
Prior art keywords
lymphocytes
composition
exchange
population
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69922090T
Other languages
English (en)
Other versions
DE69922090T2 (de
Inventor
David Klatzmann
Jose Cohen
Olivier Boyer
Veronique Thomas-Vaslin
Jean-Loup Salzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie Paris 6
Original Assignee
Universite Pierre et Marie Curie Paris 6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie Paris 6 filed Critical Universite Pierre et Marie Curie Paris 6
Publication of DE69922090D1 publication Critical patent/DE69922090D1/de
Application granted granted Critical
Publication of DE69922090T2 publication Critical patent/DE69922090T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69922090T 1998-07-10 1999-07-08 Austausch von T-Lymphozyten Expired - Lifetime DE69922090T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808952 1998-07-10
FR9808952A FR2780891A1 (fr) 1998-07-10 1998-07-10 Echange de lymphocytes t

Publications (2)

Publication Number Publication Date
DE69922090D1 true DE69922090D1 (de) 2004-12-30
DE69922090T2 DE69922090T2 (de) 2005-12-01

Family

ID=9528575

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922090T Expired - Lifetime DE69922090T2 (de) 1998-07-10 1999-07-08 Austausch von T-Lymphozyten

Country Status (7)

Country Link
EP (1) EP0972518B1 (de)
JP (1) JP2002520262A (de)
AT (1) ATE283057T1 (de)
DE (1) DE69922090T2 (de)
ES (1) ES2234220T3 (de)
FR (1) FR2780891A1 (de)
WO (1) WO2000002520A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
EP1294699B1 (de) 2000-05-12 2016-04-13 Genzyme Corporation Modulatoren des tnf-alpha-signalweges
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
EP1400534B1 (de) * 2002-09-10 2015-10-28 Affimed GmbH Menschlicher CD3-spezifischer Antikörper mit immunosupressiven Eigenschaften
CA2525519A1 (en) 2003-05-08 2004-12-02 Xcyte Therapies, Inc. Generation and isolation of antigen-specific t cells
EP2201103B1 (de) * 2007-10-12 2012-06-27 Université Pierre et Marie Curie (Paris 6) Behandlung von tumoren mit t-lymphozyt-zubereitungen
WO2009053631A2 (fr) * 2007-10-12 2009-04-30 Universite Pierre Et Marie Curie Methode d'optimisation des greffes de cellules sanguines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06298654A (ja) * 1993-04-12 1994-10-25 Sumitomo Electric Ind Ltd 抗原特異的免疫抑制剤
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells
AU5673496A (en) * 1995-05-04 1996-11-21 Arch Development Corporation Methods for modulating t cell survival by modulating bcl-xl protein level
NZ333053A (en) * 1996-05-31 2000-06-23 Genetic Therapy Inc Use of an interaction agent or T-cells having polynucleotides encoding negative selective markers to prevent graft-versus-host disease

Also Published As

Publication number Publication date
ES2234220T3 (es) 2005-06-16
WO2000002520A3 (fr) 2000-03-23
ATE283057T1 (de) 2004-12-15
EP0972518A2 (de) 2000-01-19
EP0972518B1 (de) 2004-11-24
EP0972518A3 (de) 2000-01-26
JP2002520262A (ja) 2002-07-09
DE69922090T2 (de) 2005-12-01
WO2000002520A2 (fr) 2000-01-20
FR2780891A1 (fr) 2000-01-14

Similar Documents

Publication Publication Date Title
FR2621245B1 (fr) Table d'operation orthopedique pour membres et notamment pour membres inferieurs
FR2606028B1 (fr) Systeme a enzyme stabilisee, procede pour le preparer, compositions detergentes le contenant et leurs procedes d'utilisation pour nettoyer des tissus salis
FR2668063B1 (de)
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
JPS6471889A (en) Novel 6-acyl-(6h)-dibenzo(c,e)(1,2)oxaphosphorine- 6-oxide, manufacture and use as photoinitiator
DE69922090D1 (de) Austausch von T-Lymphozyten
IT8722064A0 (it) Dispositivo per la separazione di impurita', come rifiuti, pelature e simili per una carda.
IT1226210B (it) Procedimento per l'estrazione e la purificazione di dna
DE3767178D1 (de) Heisshaertbare stoffgemische enthaltend substituierte bicyclo (2.2.1)hept-5-en-2,3-dicarbonsaeureimide und polymaleinimide.
FR2606677B1 (fr) Applicateur de liquide, par exemple applicateur de produit de beaute, instrument d'ecriture, etc.
IT8619044A0 (it) Dispositivo per l'individuazione, la selezione e la rimozione di sostanze estranee mescolate.
FR2580494B1 (fr) Composition cosmetique pour le traitement des cheveux, notamment des cheveux gras a base d'un extrait de millefeuille (achillea millefolium l)
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
FR2763596B1 (fr) Produits stabilisants, compositions et concentres les contenant, et leur procede d'utilisation
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
IL79249A0 (en) Herbicidal compositions containing haloalkylthioquinazoline di(thi)ones,and some new such compounds
GB2187140B (en) Artist's portfolio
Yoshihashi Interaction Design
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
IT8720208A0 (it) Macchina per l'impiego forestale destinata in particolare per la lavorazione di alberi.
IT1213786B (it) Contenitore-distributore diprodotti cosmetici in barra.
FR2636234B1 (fr) Composition, procede de preparation et utilisation d'une lotion capillaire regeneratrice
ZA868913B (en) Solution of 3-alkylthio-4-amino-6-tert-butyl-1,2,4-triazin-5-ones in normally liquid n-aryl-n-alkoxyalkyl-haloacetamides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition